ADAM17 and prostate cancer: ADAM17-mediated cleavage of TGF-α also plays a role in prostate cancer, where the overexpression of ADAM17 correlates with invasive characteristics, the activation of the EGFR-MEK-ERK pathway, and increased MMP-2 and MMP-9 levels.